Donanemab detects a minor fraction of amyloid-β plaques in post-mortem brain tissue of patients with Alzheimer's disease and Down syndrome.
Yvonne BouterHendrik LiekefeldSteffen PichloAnna Celine WesthoffLydia FennPreeti BakraniaThomas A BayerPublished in: Acta neuropathologica (2022)